IM HealthScience (IMH) was founded in 2012 by a group of senior pharmaceutical executives as a science driven and patient centric company whose mission is to research, develop and make available state of the art medical foods for gastrointestinal conditions such as Irritable Bowel Syndrome (IBS) and Functional Dyspepsia (FD).

IMH is a family company rooted in the all too forgotten adage that the patient comes first and doing the right thing will always win out in the long term.

As a small, private organization, IMH is committed to putting patients before profits. IMH is also committed to bringing cutting edge life science and world class clinical research to the medical foods industry.

IM HealthScience seeks exceptional people who aspire to execute with excellence, who take pride in building something new and who genuinely care about people.
IMH firmly believes that medical foods can improve the lives of patients for whom dietary and lifestyle changes are not enough.